/
MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

APYX — Apyx Medical Corporation Common Stock

Nasdaq

Apyx Medical Corporation Common Stock

Back to Screener
$2.55
+0.05(+2.00%)
O
2.51
H
2.60
L
2.50
V
51.23K
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Apyx Medical Corporation Common Stock Statistics

Total Valuation

Market Cap$124.69M
Enterprise Value$132.57M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding42.12M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio8.23
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ratio94.10
PEG Ration/a

Enterprise Valuation

EV / Earnings-61.86
EV / Salesn/a
EV / EBITDA-309.02
EV / EBIT-210.10
EV / FCF-209.76

Financial Position

Current Ratio5.80
Quick Ration/a
Debt / Equity2.98
Debt / EBITDA-90.96
Debt / FCF-61.74
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)-16.37%
Return on Assets (ROA)-3.40%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$-10,454
Employee Count205
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax$143.00K
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+22.01%
50-Day Moving Average$3.21
200-Day Moving Average$3.71
Relative Strength Index (RSI)33.33
Average Volume (20 Days)156,767

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$7.92M
Operating Income-$911.00K
Pretax Income-$2.00M
Net Income-$2.14M
EBITDA-$429.00K
EBIT-$631.00K
Loss Per Share$-0.05

Balance Sheet

Cash & Cash Equivalents$31.14M
Total Debt$39.02M
Net Cash-$7.88M
Net Cash Per Share$-0.19
Equity (Book Value)$13.09M
Book Value Per Share$0.31
Working Capital$45.35M

Cash Flow

Operating Cash Flow$1.32M
Capital Expenditures-$60.00K
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow-$632.00K
FCF Per Share$-0.02

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yieldn/a
FCF Yield-0.51%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a